Table 1.
Effect of HLU and SclAb-II Treatment on Femoral Trabecular and Cortical Bone Microarchitecture, Assessed by μCT
Controls |
HLU |
ANOVA results |
|||||
---|---|---|---|---|---|---|---|
Site | Vehicle | SclAbll | Vehicle | SclAbll | pload | ptreatment | pinteraction |
Distal trabecular | |||||||
BV/TV (%) | 10.3 ± 0.4b | 32.0 ± 1.5a,b | 8.0 ± 0.3 | 21.7 ± 1.2a | <0.0001 | <0.0001 | <0.0001 |
Tb.N (mm—1) | 3.86 ± 0.04b | 4.32 ± 0.05a,b | 3.72 ± 0.05 | 4.05 ± 0.05a | 0.0006 | <0.0001 | 0.1 |
Tb.Th (mm) | 0.054 ± 0.001b | 0.097 ± 0.002a,b | 0.048 ± 0.001 | 0.075 ± 0.003a | <0.0001 | <0.0001 | <0.0001 |
Tb.Sp (mm) | 0.252 ± 0.003b | 0.198 ± 0.003a,b | 0.261 ± 0.003 | 0.217 ± 0.005a | 0.008 | <0.0001 | 0.2 |
ConnD (mm—3) | 74 ± 3b | 107 ± 3a | 55 ± 5 | 108 ± 3a | 0.3 | <0.0001 | 0.06 |
SMI | 2.99 ± 0.06 | 1.4 ± 0.12a,b | 3.05 ± 0.05 | 1.98 ± 0.08a | 0.01 | <0.0001 | 0.002 |
Distal cortical | |||||||
Tt.CSA (mm2) | 2.49 ± 0.03 | 2.68 ± 0.05a,b | 2.48 ± 0.05 | 2.54 ± 0.05 | 0.3 | 0.008 | 0.9 |
Ct.BA (mm2) | 0.71 ± 0.01b | 0.96 ± 0.01a,b | 0.57 ± 0.01 | 0.80 ± 0.02a | <0.0001 | <0.0001 | 0.7 |
Ct.BA/TA (%) | 28.5 ± 0.4b | 35.5 ± 0.7a,b | 22.8 ± 0.4 | 31.5 ± 0.2a | <0.0001 | <0.0001 | 0.06 |
Ct.Por (%) | 5.9 ± 0.2b | 5.3 ± 0.2 | 7.9 ± 0.4 | 5.3 ± 0.4a | 0.0006 | <0.0001 | 0.003 |
Ct.Th (mm) | 0.12 ± 0.002b | 0.15 ± 0.002a,b | 0.10 ± 0.001 | 0.13 ± 0.001a | <0.0001 | <0.0001 | 0.08 |
pMOl (mm4) | 0.50 ± 0.01b | 0.71 ± 0.02a,b | 0.39 ± 0.01 | 0.57 ± 0.02a | <0.0001 | <0.0001 | 0.3 |
Midshaft cortical | |||||||
Tt.CSA (mm2) | 1.56 ± 0.018 | 1.69 ± 0.024a,b | 1.54 ± 0.030 | 1.58 ± 0.026 | 0.03 | 0.001 | 0.05 |
Ct.BA (mm2) | 0.66 ± 0.010b | 0.86 ± 0.015a,b | 0.55 ± 0.010 | 0.70 ± 0.012a | <0.0001 | <0.0001 | 0.02 |
Ct.MA (mm2) | 0.90 ± 0.014b | 0.83 ± 0.013a | 0.99 ± 0.023 | 0.88 ± 0.016a | 0.0004 | <0.0001 | 0.2 |
Ct.BA/TA (%) | 42.1 ± 0.5b | 50.8 ± 0.4a,b | 35.8 ± 0.5 | 44.2 ± 0.3a | <0.0001 | <0.0001 | 0.04 |
Ct.Th (mm) | 0.16 ± 0.002b | 0.21 ± 0.003a,b | 0.13 ± 0.002 | 0.17 ± 0.002a | <0.0001 | <0.0001 | 0.03 |
TMD (mgHA/cm3) | 1148 ± 5 | 1161 ± 8 | 1135 ± 4 | 1147 ± 7 | 0.09 | 0.1 | 0.7 |
pMOI (mm4) | 0.28 ± 0.01b | 0.37 ± 0.01a,b | 0.24 ± 0.01 | 0.29 ± 0.01a | <0.0001 | <0.0001 | 0.04 |
Values are mean ± SEM. BV/TV = bone volume fraction; CON = control; ConnD = connectivity density; Ct.BA = cortical bone area; Ct.BA/TA = cortical bone area fraction; Ct.MA = medullary area; Ct.Por = cortical porosity; Ct.Th = cortical thickness; HLU = hindlimb unloaded; pMOl = polar moment of inertia; SclAbll = sclerostin antibody; SMI = structure model index; Tb.N = trabecular number; Tb.Th = trabecular thickness; Tb.Sp = trabecular separation; TMD = tissue mineral density; Tt.CSA = total cross-sectional area; VEH = vehicle.
p < 0.05 SclAbll versus VEH within loading condition.
p < 0.05 CON versus HLU within treatment condition.